Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
Conditions: Coronary Artery Disease; ECG Abnormalities From Contrast Agents Interventions: Drug: Iodixanol; Drug: Iohexol Sponsor: Minneapolis Heart Institute Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2021 Category: Research Source Type: clinical trials